However, to maintain its integrity, it must be stored and handled properly
Prescribers sourcing AOD-9604 for patients today are working exclusively within the 503A compounding pharmacy framework, which permits individualized preparations but does not confer approval or validated dosing guidance [4]
In the research framing this stack is kept clear of anything that pushes GH or IGF-1 from a third direction at the same time exogenous GH itself, additional GHRPs, or high-dose insulin protocols because the compounding effect on IGF-1 and glucose is precisely the risk the monitoring caveats exist to catch
Both remain on the FDAs restricted compounding list as of May 2026
Dysfunctional gut receptors of the enteric nervous system, as well as genetic aberrations of the enteric nervous system, the central nervous system, and the connections between them, have all been associated with gut disorders (Snoek et al., 2010